Bailleux, Caroline and Gal, Jocelyn and Chamorey, Emmanuel and Mograbi, Baharia and Milano, Gérard (2024) Artificial Intelligence and Anticancer Drug Development—Keep a Cool Head. Pharmaceutics, 16 (2). p. 211. ISSN 1999-4923
pharmaceutics-16-00211-v2.pdf - Published Version
Download (677kB)
Abstract
Artificial intelligence (AI) is progressively spreading through the world of health, particularly in the field of oncology. AI offers new, exciting perspectives in drug development as toxicity and efficacy can be predicted from computer-designed active molecular structures. AI-based in silico clinical trials are still at their inception in oncology but their wider use is eagerly awaited as they should markedly reduce durations and costs. Health authorities cannot neglect this new paradigm in drug development and should take the requisite measures to include AI as a new pillar in conducting clinical research in oncology.
Item Type: | Article |
---|---|
Subjects: | Oalibrary Press > Multidisciplinary |
Depositing User: | Managing Editor |
Date Deposited: | 01 Feb 2024 06:06 |
Last Modified: | 01 Feb 2024 06:06 |
URI: | http://asian.go4publish.com/id/eprint/3637 |